News
AZTA
24.26
+3.99%
0.93
Should Azenta’s (AZTA) New Multiomics President Reshape Confidence in Its Long-Term Genomics Strategy?
Simply Wall St · 1d ago
Weekly Report: what happened at AZTA last week (0406-0410)?
Weekly Report · 1d ago
Azenta Reshapes Multiomics Leadership and Executive Compensation
TipRanks · 04/07 13:14
Azenta names Trey Martin Multiomics president as Ginger Zhou steps down
Reuters · 04/07 12:15
Press Release: Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Dow Jones · 04/07 12:15
Azenta Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 04/06 16:38
Evercore ISI Group Maintains Outperform on Azenta, Lowers Price Target to $35
Benzinga · 04/06 16:28
Weekly Report: what happened at AZTA last week (0330-0403)?
Weekly Report · 04/06 10:35
Assessing Azenta (AZTA) Valuation After Recent Share Price Rebound And Margin Expansion Hopes
Simply Wall St · 04/05 09:20
Stocks to Watch: PMGC, Azenta
Dow Jones · 04/02 22:50
Azenta Weighs Options After Thelema Fails to Secure Acquisition Financing in Time
Dow Jones · 04/02 20:55
Azenta Faces Delay in B Medical Systems Divestiture
TipRanks · 04/02 20:38
AZENTA INC - AGREEMENT NOT AMENDED OR TERMINATED; COMPANY EVALUATING POTENTIAL PATHS FORWARD - SEC FILING
Reuters · 04/02 20:13
Azenta says B Medical sale misses March 31 close as buyer financing delayed
Reuters · 04/02 20:12
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 04/01 21:05
Azenta price target lowered to $35 from $40 at Jefferies
TipRanks · 04/01 18:00
Weekly Report: what happened at AZTA last week (0323-0327)?
Weekly Report · 03/30 10:35
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
Barchart · 03/27 13:16
Azenta: Life Science Player Fails To Come To Life
Seeking Alpha · 03/24 22:38
Weekly Report: what happened at AZTA last week (0316-0320)?
Weekly Report · 03/23 10:31
More
Webull provides a variety of real-time AZTA stock news. You can receive the latest news about Azenta Inc through multiple platforms. This information may help you make smarter investment decisions.
About AZTA
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.